Sections

Home | Cancers

Cancers

New genetic findings help explain inherited predisposition to myeloma

Researchers have identified eight new genetic variations in the human genome that could be linked to an increased risk of developing myeloma. ...

New anti-cancer strategy mobilizes both innate and adaptive immune response

Though a variety of immunotherapy-based strategies are being used against cancer, they are often hindered by the inability of the immune response ...

Women with BRCA1 Gene Mutation at Higher Risk of Deadly Uterine Cancer

DURHAM, N.C. -- Women who carry the BRCA1 gene mutation that dramatically increases their risk of breast and ovarian cancers are also at higher risk for a lethal form of uterine cancer, according to a study led by a Duke Cancer Institute researcher. ... Full story

Group of rare blood cancers respond to new treatment pioneered by Stanford physician

Patients with a group of cancers known as advanced systemic mastocytosis have few treatment options. A drug called midostaurin showed promise in an international clinical trial led by a Stanford physician. ... Full story

New method detects telomere length for research into cancer, aging

DALLAS – UT Southwestern Medical Center cell biologists have identified a new method for determining the length of telomeres, the endcaps of chromosomes, which can influence cancer progression and aging. ... Full story

SLU Research: Americans Pay Highest Prices in the World for Cancer Medications

Yifan Tu, M.D., Ph.D., assistant professor in the Division of Hematology and Oncology at Saint Louis University, was the third author in a recent study ... Full story

Tailored health campaigns to spot cancer

Tailored health campaigns could help ethnic groups spot cancer symptoms earlier ... Full story

IU study finds testicular cancer survivors may have hearing loss after cisplatin therapy

INDIANAPOLIS – Many testicular cancer survivors experience hearing loss after cisplatin-based chemotherapy, according to researchers at Indiana University. ... Full story

Researchers Develop Method to Map Cancer Progression

A team of scientists has developed a computational method to map cancer progression, an advance that offers new insights into the factors that spur this affliction as well as new ways of selecting effective therapies. ... Full story

EMA ESMO Workshop - Optimising the use of single arm trials in cancer drug development

London, United Kingdom – The European Medicines Agency (EMA) and the European Society for Medical Oncology (ESMO) will host a workshopon single-arm trials (SATs) at the EMA headquarters in London, UK, on June 30th 2016. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 8521 | displaying: 1 - 10